News Releases

Amended Patent Infringement Complaint against Thermogenesis & Celling Technologies

PLYMOUTH, Mass., Feb. 20, 2013 /PRNewswire/ -- Harvest Technologies Corporation (Harvest) announced that it filed an amended patent infringement complaint on February 15, 2013 in the US District Court of Delaware against ThermoGenesis Corporation (ThermoGenesis) and Celling Technologies LLC. The complaint was amended to include Celling Technologies and alleges that the ThermoGenesis' Res-Q™ 60 BMC system, also sold by Celling Technologies as the ART 21® BMC System, infringes two patents for which Harvest Technology owns the rights.

Harvest Technologies Corporation Granted CE Mark for Expanded Clinical Indication for Treatment of No-Option Critical Limb Ischemia

PLYMOUTH, Mass., Nov. 12, 2012 /PRNewswire/ -- Harvest Technologies, a leader in advancing cellular therapies, is pleased to announce CE Marking for an expanded clinical indication for its SmartPReP®2 Bone Marrow Aspiration Concentration System (BMAC®2) product. 

Harvest Technologies Files Patent Infringement Complaint against Thermogenesis Corporation

PLYMOUTH, Mass., Oct. 24, 2012 /PRNewswire/ -- Harvest Technologies Corporation (Harvest) announced that it filed a patent infringement complaint on October 24, 2012 in the US District Court of Delaware against ThermoGenesis Corporation (ThermoGenesis). The complaint alleges that ThermoGenesis' Res-Q™ 60 BMC system (*also known as ART 21®) infringes two patents for which Harvest Technology owns the rights. These patents relate to Harvest's proprietary floating shelf technology that has been shown in studies to provide superior cellular concentration.